Welcome to our dedicated page for Newcourt Acquisition news (Ticker: NCAC), a resource for investors and traders seeking the latest updates and insights on Newcourt Acquisition stock.
Newcourt Acquisition Corp (NASDAQ: NCAC), a special purpose acquisition company, provides investors with centralized access to official news regarding its proposed merger with Psyence Group Inc. (CSE: PSYG) - a leader in natural psilocybin therapeutics. This page aggregates press releases, SEC filings, and strategic updates related to the business combination process and associated clinical research developments.
Users will find essential information about merger approval progress, regulatory communications, and operational updates from both companies. The resource specifically tracks developments across Psyence's three divisions: production, therapeutics, and clinical research initiatives targeting mental health treatment.
All content is sourced from verified regulatory filings and corporate communications to ensure accuracy. Visitors should bookmark this page for efficient tracking of merger milestones and review the SEC's EDGAR database for complete disclosure documents. Regular updates will reflect new developments as both companies work toward transaction completion.
Newcourt Acquisition Corp (NASDAQ: NCAC) announced modifications to its Trust Agreement Amendment related to the extension of time for completing its initial business combination. Rather than amending Section 1(c) to hold funds entirely in cash, the Company will maintain the current structure, allowing it to liquidate securities held in the trust account by October 19, 2023. If approved, the extension will allow the Company until July 22, 2023, to finalize a business combination. An amendment to the Definitive Proxy Statement will be filed with the SEC.
Newcourt Acquisition Corp announces its upsized initial public offering, successfully closing on 25,000,000 units at $10.00 each, raising $250 million in gross proceeds. The offering included 3,000,000 units from the underwriters' over-allotment option. Trading commenced on Nasdaq under the ticker 'NCACU' on October 20, 2021. Each unit comprises one Class A share and one-half redeemable warrant, with the anticipated separate trading of shares and warrants under 'NCAC' and 'NCACW.' The firm aims to target fintech businesses in emerging markets.
Newcourt Acquisition Corp announced the pricing of its upsized initial public offering (IPO) of 22,000,000 units at $10.00 each. Trading begins on Nasdaq under the ticker symbol 'NCACU' on October 20, 2021. Each unit comprises one Class A ordinary share and one-half warrant, with whole warrants priced at $11.50. The offering is expected to close on October 22, 2021, pending customary conditions. The company focuses on acquiring fintech businesses in emerging markets and has granted underwriters a 45-day option to purchase an additional 3,300,000 units.
